← Insider buys
MRNA

Moderna, Inc. · Healthcare

Director Noubar Afeyan sold $1.6M of Moderna, Inc.

Sold$1,571,090
$104.74Price
15,000Shares

What MRNA did after the filing

Filed Sep 22Copier in Sep 25
The stock from Mon, Sep 25 open, $99.52
−27.6%
S&P 500, same days
+1.5%

Measured over 30 trading days, to the Nov 6 close.

Traded Wed, Sep 20. Filed Fri, Sep 22, 7:00 PM ET, after the close. Returns use the Sep 25 open and the Nov 6 close. Not investment advice.